ICU Medical Inc (ICUI)

Return on assets (ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands -29,655 -28,044 -48,490 -46,030 -74,286 -38,825 5,464 41,336 103,135 109,352 103,257 93,767 86,870 81,369 82,946 86,871 101,035 73,039 46,695 54,916
Total assets US$ in thousands 4,378,440 4,376,860 4,463,040 4,470,630 4,515,640 4,450,480 4,590,000 4,746,730 1,880,740 1,839,350 1,802,840 1,765,230 1,763,690 1,729,540 1,859,060 1,816,980 1,692,380 1,637,780 1,622,920 1,613,270
ROA -0.68% -0.64% -1.09% -1.03% -1.65% -0.87% 0.12% 0.87% 5.48% 5.95% 5.73% 5.31% 4.93% 4.70% 4.46% 4.78% 5.97% 4.46% 2.88% 3.40%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $-29,655K ÷ $4,378,440K
= -0.68%

The return on assets (ROA) for ICU Medical, Inc. has been fluctuating over the past eight quarters. In the most recent quarter, Q4 2023, the ROA was -0.68%, which indicates that the company generated a negative return on its assets during that period. This represents a slight improvement compared to the previous quarter's ROA of -0.64%. However, the ROA has been negative for the past six quarters, suggesting that the company has been struggling to effectively generate profits from its assets.

It is important for investors and stakeholders to monitor the company's ROA closely as it provides insights into the efficiency of management in utilizing the company's assets to generate profits. The negative trend in ROA over the past several quarters may indicate potential operational inefficiencies or challenges that ICU Medical, Inc. is facing in generating profits from its assets. Further analysis and investigation into the company's operations and financial performance are warranted to fully understand the factors contributing to the negative ROA trend.


Peer comparison

Dec 31, 2023